Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial. - ActiVitD trial

未提供0 个研究点目标入组 130 人开始时间: 2023年4月28日最近更新: 2023年10月23日

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•-Men and both pre- and postmenopausal women who have had Roux-en-Y-gastric bypass surgery and present with secondary hyperparathyroidism after surgery, with a vitamin D sufficient state (>50 nmol/l), and only on standard supplementation, are included.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 130
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•-Patients who are already on active treatment for osteoporosis before inclusion
•-Patients with chronic kidney disease defined as eGFR < 60 ml/min
•-Patients who had a bariatric intervention before and are re-operated
•-Patients that are on chronic steroid use, for example for inflammatory conditions
•-Patients that appear to have hypercalcemia on screening
•-Patients with known inflammatory conditions (i.e. rheumatoid arthritis)
•-Patients that have an active pregnancy wish

发起方

未提供